Skip to content
2000
Volume 12, Issue 1
  • ISSN: 1574-3624
  • E-ISSN: 2212-389X

Abstract

Background: Aryl hydrocarbon receptor (AhR) is an exogenous ligand-activating or constitutively active transcription factor. AhR regulates cellular differentiation, cell migration and other molecular and cellular processes. In general, AhR is biologically a very complex molecule in terms of its structure and functions in stemness, differentiation and clinical diseases. Here we review the debated issue of AhR in stem cell and cancer stem cell signaling. Methods: We searched literatures in PubMed and Google Scholar for related articles to review the AhR function and signal transduction in stem cells and cancer stem cells. Experimental data and results were analyzed. Results: It has been shown that AhR is an oncogenic protein but recent studies suggest that AhR can also inhibit cancer signaling through cancer stem cell pathways which are mostly common in OCT4. AhR either activates or inhibits tumorigenesis possibly through regulation of stemness or differentiation. Furthermore, how AhR can switch this function is largely unknown. Conclusion: AhR may inhibit or promote stem cell/cancer stem cell signaling through molecular switches of ageing, tissue specific signaling, ligand, and systems interaction networks. Targeting these signaling would provide a new avenue for efficient therapy in precision medicine.

Loading

Article metrics loading...

/content/journals/cst/10.2174/1574362412666170207103318
2017-04-01
2025-09-03
Loading full text...

Full text loading...

/content/journals/cst/10.2174/1574362412666170207103318
Loading

  • Article Type:
    Research Article
Keyword(s): AhR; cancer; molecular switch; OCT4; stem cell; TCDD
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test